Journal Guide

Effective with the 2011 volume, this journal will be published in an online-only format Hematological Oncology considers for publication articles dealing with experimental and clinical aspects of neoplastic diseases of the hemopoietic and lymphoid systems and relevant related matters. Translational studies applying basic science to clinical issues are particularly welcomed. Manuscripts dealing with the following areas are encouraged:

The purpose of Hematology, also known as the ASH Education Program Book, is to provide a series of up-to-date review articles applicable to the current practice of hematology -- whether the practice be community-based, academic, institutional, training, or a combination thereof. Each chapter of the book relates to one of the education program sessions at the annual meeting. The articles summarize the topic and provide sufficient references so that they can be used by a general hematology practitioner who could not attend the ASH annual meeting.

Hematology is an international journal publishing original and review articles in the field of general hematology, including oncology, pathology, biology, clinical research and epidemiology. Of the fixed sections, annotations are accepted on any general or scientific field: technical annotations covering current laboratory practice in general hematology, blood transfusion and clinical trials, and current clinical practice reviews the consensus driven areas of care and management.

Hematology aims to bridge the interests and practices of both those carrying out laboratory work and those whose main inclination is towards patient care. The journal provides a forum where the clinical aspects of any published material will be emphasised.

The editors welcome papers from all related areas of research including:
•general hematology
•oncology
•pathology
•biology
•clinical research
•epidemiology
•thalassemias and leukemias

Hematology/Oncology Clinics of North America updates you on the latest trends in patient management, keeps you up to date on the newest advances, and provides a sound basis for choosing treatment options. Under the direction of an experienced guest editor, each issue focuses on a single topic in hematology and oncology, including hemostasis and thrombosis, molecular and cellular basis of hematology, coagulation disorders, and cancers8212;bone, gastrointestinal, head and neck, lymphomas, neuroendocrine, breast, renal cell, melanoma, and more.
Hematology/Oncology Clinics of North America is published six times each year, in February, April, June, August, October, and December.

Hematology Oncology and Stem Cell Therapy is an international, peer-reviewed, open access journal that provides a vehicle for publications of high-quality clinical as well as basic science research reports in hematology and oncology. The contents of the journal also emphasize the growing importance of hematopoietic stem cell therapy for treatment of various benign and malignant hematologic disorders and certain solid tumors.The journal prioritizes publication of original research articles but also would give consideration for brief reports, review articles, special communications, and unique case reports. It also offers a special section for clinically relevant images that provide an important educational value.

Hemodialysis International was originally an annual publication containing the Proceedings of the International Symposium on Hemodialysis held in conjunction with the Annual Dialysis Conference. Since 2003, Hemodialysis International is published quarterly and contains original papers on clinical and experimental topics related to dialysis in addition to the Annual Dialysis Conference supplement. This journal is a must-have for nephrologists, nurses, and technicians worldwide. Quarterly issues of Hemodialysis International are included with your membership to the International Society for Hemodialysis. The journal contains original articles, review articles, and commentary to keep readers completely updated in the field of hemodialysis. Edited by international and multidisciplinary experts, Hemodialysis International disseminates critical information in the field.

Hemoglobin is a journal in the English language for the rapid communication of research involving hemoglobin, diseases affecting hemoglobin, and the red blood cell components interacting with hemoglobin. Fundamental, practical, genetic, epidemiological, and clinical aspects will be considered.

Hämostaseologie is an interdisciplinary specialist journal on the complex topics of haemorrhages and thromboembolism and is aimed not only at haematologists, but also at a wide range of specialists from clinic and practise. The readership consequently includes both specialists for internal medicine as well as for surgical diseases. In each issue we publish predominantly German language review articles in basic research, diagnosis and therapies concerning a specific problem area. Additionally, current topics of interest are brought to the fore in original articles and brief notices. Reports from international literature, congresses, book reviews and highlights from research and industry further complete the scope of the Journal. The congress issue publishes abstracts from the annual meeting of the Gesellschaft für Thrombose- und Hämostaseforschung e. V. (GTH).

An international team of editors and scientific advisors maintains the high standard of quality set by Immunobiology since it first appeared in 1909. With contributions by prominent experts in the field, the journal is a focal point of scientific interest. Published research findings are a vital link between scientists and clinicians active at the experimental levels of immunobiology, serology, hematology, allergy, infectious diseases, transplantation, and nonspecific resistance. A new fast track line for high priority publications will speed up communication between scientists all over the world. Immunobiology, the world's first immunological journal, carries on the tradition set by such distinguished scientists as Carl Oluf Jensen, Sibasaburo Kitasato, Karl Landsteiner, Max Neisser and others.

Indian Journal of Hematology and Blood Transfusion is a medium for propagating and exchanging ideas within the medical community. It publishes peer-reviewed articles on a variety of aspects of clinical hematology, laboratory hematology and hemato-oncology. The journal exists to encourage scientific investigation in the study of blood in health and in disease; to promote and foster the exchange and diffusion of knowledge relating to blood and blood-forming tissues; and to provide a forum for discussion of hematological subjects on a national scale.The Journal is the official publication of The Indian Society of Hematology & Blood Transfusion.

The International Journal of Clinical Oncology (IJCO) welcomes original research papers on all aspects of clinical oncology that report the results of novel and timely investigations. Reports on clinical trials are encouraged. Experimental studies will also be accepted if they have obvious relevance to clinical oncology. Membership in the Japan Society of Clinical Oncology is not a prerequisite for submission to the journal. Papers are received on the understanding that: their contents have not been published in whole or in part elsewhere; that they are subject to peer review by at least two referees and the Editors, and to editorial revision of the language and contents; and that the Editors are responsible for their acceptance, rejection, and order of publication.

This official journal of the Japanese Society of Hematology covers all aspects of the field of hematology, namely, erythrocytes, leukocytes and hematopoiesis, hemostasis, thrombosis and vascular biology, hematological malignancies, transplantation, and cell therapy. The International Journal of Hematology has a long history of publishing leading research in the field. It features articles that contribute to progress in research not only in basic hematology but also in clinical hematology. The expanded Progress in Hematology section integrates such relevant fields as the cell biology of stem cells and cancer cells, and clinical research in inflammation, cancer, and thrombosis. In addition, the journal includes reports on results of clinical trials, which help foster communication among researchers in the growing field of modern hematology. The journal provides the best of up-to-date information on modern hematology, presenting readers with high-impact, original work focusing on pivotal issues.

International Journal of Laboratory Hematology is an international journal providing a forum for the communication of new developments, research topics and the practice of clinical and laboratory haematology. The journal publishes: invited reviews; full length original articles; case reports; technical reports; regular book reviews; notices and correspondence In addition, the Journal publishes Synoptics, an occasional review series presenting a written summary of meetings which readers might have missed. An active and positive editorial policy ensures that work of the highest scientific standard is reported, promoting effective communication amongst practising haematologists.